In another move designed to reduce the US' reliance on imported medicines, the FDA has launched a pilot of fast-track reviews for generics tested and made in domestic facilities. According to the ...

President Trump has delayed imposing tariffs on pharmaceuticals to allow for more negotiations with drug companies. (Francis Chung/Bloomberg News) The Trump administration says it doesn't plan to ...

Java Development Kit (JDK) 26, a planned update to standard Java due March 17, 2026, has gathered nine features so far. The latest slated for the release include ahead-of-time object caching, an ...

President Trump said he expects to reach pricing deals with more drug companies following the Pfizer announcement. Photo: Win McNamee/Getty Images WASHINGTON—The Trump administration said it isn’t ...

The Trump administration is reportedly planning to exclude imported generic drugs from tariffs. White House spokesman Kush Desai told the Wall Street Journal that "the administration is not actively ...

The Trump administration has abandoned plans for tariffs on imported generic drugs, a move bringing significant relief to Indian pharmaceutical companies. This decision averts potential price hikes ...

Esperion has entered into a settlement agreement with Dr. Reddy’s to resolve the patent litigation in response to Dr. Reddy’s seeking approval to market a generic version of Nexletol and Nexlizet ...

Last month, US President Donald Trump announced 100% import tariffs on branded and patented pharmaceutical products, making investors jittery. However, this development had little effect on Indian ...

The Delhi High Court has dismissed Roche’s appeal seeking an injunction against Natco Pharma in a case involving the Swiss company’s rare diseases drug risdiplam. Patient groups say the decision will ...

Pharma shares gained on Thursday, lifted by reports that the US Administration may exclude generic medicines from proposed new import tariffs. The Nifty pharma index climbed 1.05%, with key stocks ...

The pharma sector is in focus and all pharma stocks are surging. This is after a Wall Street Journal report indicated that the Trump administration may not impose tariffs on generic medicines. There ...